[1]
Remenčiūtė, M. et al. 2024. The Effect of Calcitonin Gene-Related Peptide Monoclonal Antibodies on Quality of Life among Migraine Patients: Pilot Study at the Hospital of Lithuanian University of Health Sciences Kaunas Clinics. Acta medica Lituanica. 31, 1 (May 2024), 41–51. DOI:https://doi.org/10.15388/Amed.2024.31.1.12.